You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 20, 2024

Details for New Drug Application (NDA): 020427

✉ Email this page to a colleague

« Back to Dashboard

NDA 020427 describes SABRIL, which is a drug marketed by Lundbeck Pharms Llc and is included in two NDAs. It is available from one supplier. Additional details are available on the SABRIL profile page.

The generic ingredient in SABRIL is vigabatrin. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the vigabatrin profile page.
Summary for 020427
Applicant:Lundbeck Pharms Llc
Formulation / Manufacturing:see details
Pharmacology for NDA: 020427
Medical Subject Heading (MeSH) Categories for 020427
Suppliers and Packaging for NDA: 020427
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SABRIL vigabatrin TABLET;ORAL 020427 NDA Lundbeck Pharmaceuticals LLC 67386-111 67386-111-01 100 TABLET, FILM COATED in 1 BOTTLE (67386-111-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Aug 21, 2009TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.